<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/525"/><api:result><api:object category="publication" id="525" last-affected-when="2024-03-27T20:50:48.087+00:00" last-modified-when="2024-03-27T20:50:48.087+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/525" created-when="2010-05-17T13:46:22.207+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1333159" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1523-1747.1999.00739.x" last-modified-when="2023-04-23T13:29:24.34+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>John W</api:first-names><api:separate-first-names><api:first-name>John</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>Mark</api:first-names><api:separate-first-names><api:first-name>Mark</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Neil</api:last-name><api:initials>SM</api:initials><api:first-names>Sheila Mac</api:first-names><api:separate-first-names><api:first-name>Sheila</api:first-name><api:first-name>Mac</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>Robert</api:first-names><api:separate-first-names><api:first-name>Robert</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>Ghanem</api:first-names><api:separate-first-names><api:first-name>Ghanem</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>Ian G</api:first-names><api:separate-first-names><api:first-name>Ian</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1523-1747.1999.00739.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1523-1747.1999.00739.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1523-1747.1999.00739.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Investigative Dermatology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1523-1747.1999.00739.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>22</api:day><api:month>4</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte-Stimulating Hormone Inhibits NF-κB Activation in Human Melanocytes and Melanoma Cells</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record><api:record format="native" id="94550" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032880002" last-modified-when="2024-03-13T14:35:40.467+00:00"><api:citation-count>68</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>α-Melanocyte-stimulating hormone is produced by several different cell types including neural cells, endothelial cells, monocytes, and keratinocytes. A biologic role in melanocyte pigmentation is widely recognized, but more recent studies describe a part in modulating inflammatory and immune responses. The aim of the this study was to investigate the mechanism by which α-melanocyte-stimulating hormone antagonizes proinflammatory cytokine action. We report that α-melanocyte- stimulating hormone (10-9 M) was effective in opposing a tumor necrosis factor-α stimulated increase in NF-κB DNA binding activity in: (i) normal ocular melanocytes; (ii) cells cultured from ocular melanoma tumors; and (iii) two cutaneous melanoma cell lines. NF-κB is activated by many inflammatory mediators and controls transcription of genes required for immune and inflammatory responses. The transcription factor complex was positively identified as the p50/p65 heterodimer, recognized to have transcriptional activating potential. Maximum reduction of NF-κB DNA binding activity with α-melanocyte-stimulating hormone was detected 2 h after cellular stimulation and varied from between 53% and 18% depending on cell type. Whereas the acute inhibitory effects could be mimicked by elevating cyclic adenosine monophosphate, α-melanocyte-stimulating hormone was not found to have any effect on the relative level of IκBα protein expression over 24 h. These data show that α-melanocyte-stimulating hormone has a pronounced effect on NF-κB activity in melanocytes and melanoma cells, identifying a specific dimeric complex, and suggest this to be a key pathway by which immunomodulation/anti-inflammation may operate. The results may also be considered in the broader context of general inflammatory pathologies concerning cells which express α-melanocyte-stimulating hormone receptors and utilize the NF-κB signaling pathway.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35237001100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7404050294</api:identifier></api:identifiers></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Université Libre de Bruxelles</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57225241967</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Université Libre de Bruxelles</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005487533</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Hallamshire Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006936511</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004187150</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1523-1747.1999.00739.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1523-1747.1999.00739.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1523-1747.1999.00739.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10504441</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Investigative Dermatology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte-stimulating hormone inhibits NF-κB activation in human melanocytes and melanoma cells</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record><api:record format="native" id="525" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10504441" last-modified-when="2020-04-29T04:21:14.04+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Alpha-melanocyte-stimulating hormone is produced by several different cell types including neural cells, endothelial cells, monocytes, and keratinocytes. A biologic role in melanocyte pigmentation is widely recognized, but more recent studies describe a part in modulating inflammatory and immune responses. The aim of the this study was to investigate the mechanism by which alpha-melanocyte-stimulating hormone antagonizes proinflammatory cytokine action. We report that alpha-melanocyte-stimulating hormone (10-9 M) was effective in opposing a tumor necrosis factor-alpha stimulated increase in NF-kappaB DNA binding activity in: (i) normal ocular melanocytes; (ii) cells cultured from ocular melanoma tumors; and (iii) two cutaneous melanoma cell lines. NF-kappaB is activated by many inflammatory mediators and controls transcription of genes required for immune and inflammatory responses. The transcription factor complex was positively identified as the p50/p65 heterodimer, recognized to have transcriptional activating potential. Maximum reduction of NF-kappaB DNA binding activity with alpha-melanocyte-stimulating hormone was detected 2 h after cellular stimulation and varied from between 53% and 18% depending on cell type. Whereas the acute inhibitory effects could be mimicked by elevating cyclic adenosine monophosphate, alpha-melanocyte-stimulating hormone was not found to have any effect on the relative level of IkappaBalpha protein expression over 24 h. These data show that alpha-melanocyte-stimulating hormone has a pronounced effect on NF-kappaB activity in melanocytes and melanoma cells, identifying a specific dimeric complex, and suggest this to be a key pathway by which immunomodulation/anti-inflammation may operate. The results may also be considered in the broader context of general inflammatory pathologies concerning cells which express alpha-melanocyte-stimulating hormone receptors and utilize the NF-kappaB signaling pathway.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">University Division of Clinical Sciences, Section of Medicine, Clinical Sciences Center, Northern General Hospital, Sheffield, UK. j.w.haycock@shef.ac.uk</api:line></api:address></api:addresses><api:email-address>j.w.haycock@shef.ac.uk</api:email-address></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10504441</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1523-1747.1999.00739.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1523-1747.1999.00739.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1523-1747.1999.00739.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Invest Dermatol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cells, Cultured</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Melanocytes</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">NF-kappa B</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">alpha-MSH</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0022-202X(15)40617-7</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>4</api:day><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human melanocytes and melanoma cells.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record><api:record format="native" id="881885" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10504441" last-modified-when="2024-03-12T19:44:41.17+00:00"><api:citation-count>46</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Alpha-melanocyte-stimulating hormone is produced by several different cell types including neural cells, endothelial cells, monocytes, and keratinocytes. A biologic role in melanocyte pigmentation is widely recognized, but more recent studies describe a part in modulating inflammatory and immune responses. The aim of the this study was to investigate the mechanism by which alpha-melanocyte-stimulating hormone antagonizes proinflammatory cytokine action. We report that alpha-melanocyte-stimulating hormone (10-9 M) was effective in opposing a tumor necrosis factor-alpha stimulated increase in NF-kappaB DNA binding activity in: (i) normal ocular melanocytes; (ii) cells cultured from ocular melanoma tumors; and (iii) two cutaneous melanoma cell lines. NF-kappaB is activated by many inflammatory mediators and controls transcription of genes required for immune and inflammatory responses. The transcription factor complex was positively identified as the p50/p65 heterodimer, recognized to have transcriptional activating potential. Maximum reduction of NF-kappaB DNA binding activity with alpha-melanocyte-stimulating hormone was detected 2 h after cellular stimulation and varied from between 53% and 18% depending on cell type. Whereas the acute inhibitory effects could be mimicked by elevating cyclic adenosine monophosphate, alpha-melanocyte-stimulating hormone was not found to have any effect on the relative level of IkappaBalpha protein expression over 24 h. These data show that alpha-melanocyte-stimulating hormone has a pronounced effect on NF-kappaB activity in melanocytes and melanoma cells, identifying a specific dimeric complex, and suggest this to be a key pathway by which immunomodulation/anti-inflammation may operate. The results may also be considered in the broader context of general inflammatory pathologies concerning cells which express alpha-melanocyte-stimulating hormone receptors and utilize the NF-kappaB signaling pathway.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">University Division of Clinical Sciences, Section of Medicine, Clinical Sciences Center, Northern General Hospital, Sheffield, UK. j.w.haycock@shef.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-3950-3583</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1523-1747.1999.00739.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1523-1747.1999.00739.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1523-1747.1999.00739.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1523-1747</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10504441</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of investigative dermatology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cells, Cultured</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Melanocytes</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">alpha-MSH</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">NF-kappa B</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>3</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human melanocytes and melanoma cells.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record><api:record format="native" id="2909191" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1041228207" last-modified-when="2024-03-17T08:11:44.253+00:00"><api:citation-count>62</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>John W</api:first-names><api:separate-first-names><api:first-name>John</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01174076130.30</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>Mark</api:first-names><api:separate-first-names><api:first-name>Mark</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0702561451.36</api:identifier></api:identifiers></api:person><api:person><api:last-name>Neil</api:last-name><api:initials>SM</api:initials><api:first-names>Sheila Mac</api:first-names><api:separate-first-names><api:first-name>Sheila</api:first-name><api:first-name>Mac</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.015044373253.21</api:identifier></api:identifiers></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>Robert</api:first-names><api:separate-first-names><api:first-name>Robert</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Institut Jules Bordet</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address><api:address iso-country-code="BE"><api:line type="organisation">Université Libre de Bruxelles</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>Ghanem</api:first-names><api:separate-first-names><api:first-name>Ghanem</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Institut Jules Bordet</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address><api:address iso-country-code="BE"><api:line type="organisation">Université Libre de Bruxelles</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0576616237.53</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>Ian G</api:first-names><api:separate-first-names><api:first-name>Ian</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Hallamshire Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0721152077.11</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1523-1747.1999.00739.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1523-1747.1999.00739.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1523-1747.1999.00739.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10504441</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Investigative Dermatology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3204 Immunology</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">1 Underpinning research</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">1.1 Normal biological development and functioning</api:keyword><api:keyword scheme="hrcs-hc">Inflammatory and immune system</api:keyword><api:keyword scheme="mesh">Cells, Cultured</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Melanocytes</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">NF-kappa B</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">alpha-MSH</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>1.45</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte-Stimulating Hormone Inhibits NF-κB Activation in Human Melanocytes and Melanoma Cells</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record><api:record format="native" id="240764" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000082974700006" last-modified-when="2024-03-27T20:50:48.09+00:00"><api:citation-count>66</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000082974700006&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1523-1747.1999.00739.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1523-1747.1999.00739.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1523-1747.1999.00739.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1523-1747</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">243AJ</api:identifier><api:identifier scheme="pubmed">10504441</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF INVESTIGATIVE DERMATOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>cancer</api:keyword><api:keyword>immunomodulation</api:keyword><api:keyword>inflammation</api:keyword><api:keyword>pigmentation</api:keyword><api:keyword>transcription factors</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte-stimulating hormone inhibits NF-κB activation in human melanocytes and melanoma cells</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record><api:record format="native" id="23532" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000082974700006" last-modified-when="2014-07-25T11:04:00.08+01:00"><api:citation-count>50</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1264" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1264"/></api:links><api:last-name>Haycock</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wagner</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-202X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J INVEST DERMATOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>cancer</api:keyword><api:keyword>immunomodulation</api:keyword><api:keyword>inflammation</api:keyword><api:keyword>pigmentation</api:keyword><api:keyword>transcription factors</api:keyword><api:keyword>INTERCELLULAR-ADHESION MOLECULE-1</api:keyword><api:keyword>NECROSIS-FACTOR-ALPHA</api:keyword><api:keyword>POMC-DERIVED PEPTIDES</api:keyword><api:keyword>ANTIINFLAMMATORY ACTIVITY</api:keyword><api:keyword>PERIPHERAL INFLAMMATION</api:keyword><api:keyword>MSH RECEPTORS</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>PROOPIOMELANOCORTIN</api:keyword><api:keyword>MODULATION</api:keyword><api:keyword>KERATINOCYTES</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>560</api:begin-page><api:end-page>566</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>alpha-Melanocyte-stimulating hormone inhibits NF-kappa B activation in human melanocytes and melanoma cells</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>113</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Melanocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">NF-kappa B</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">alpha-MSH</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Melanocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">alpha-MSH</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">NF-kappa B</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3204 Immunology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">1 Underpinning research</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">1.1 Normal biological development and functioning</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Inflammatory and immune system</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Melanocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">NF-kappa B</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">alpha-MSH</api:keyword><api:keyword origin="record-data" source="wos-lite">cancer</api:keyword><api:keyword origin="record-data" source="wos-lite">immunomodulation</api:keyword><api:keyword origin="record-data" source="wos-lite">inflammation</api:keyword><api:keyword origin="record-data" source="wos-lite">pigmentation</api:keyword><api:keyword origin="record-data" source="wos-lite">transcription factors</api:keyword><api:keyword origin="record-data" source="wos">cancer</api:keyword><api:keyword origin="record-data" source="wos">immunomodulation</api:keyword><api:keyword origin="record-data" source="wos">inflammation</api:keyword><api:keyword origin="record-data" source="wos">pigmentation</api:keyword><api:keyword origin="record-data" source="wos">transcription factors</api:keyword><api:keyword origin="record-data" source="wos">INTERCELLULAR-ADHESION MOLECULE-1</api:keyword><api:keyword origin="record-data" source="wos">NECROSIS-FACTOR-ALPHA</api:keyword><api:keyword origin="record-data" source="wos">POMC-DERIVED PEPTIDES</api:keyword><api:keyword origin="record-data" source="wos">ANTIINFLAMMATORY ACTIVITY</api:keyword><api:keyword origin="record-data" source="wos">PERIPHERAL INFLAMMATION</api:keyword><api:keyword origin="record-data" source="wos">MSH RECEPTORS</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">PROOPIOMELANOCORTIN</api:keyword><api:keyword origin="record-data" source="wos">MODULATION</api:keyword><api:keyword origin="record-data" source="wos">KERATINOCYTES</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Dermatology &amp; Venereal Diseases</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0022-202X" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974111" title="Journal of Investigative Dermatology"><api:records><api:record source-name="summary"><api:title>Journal of Investigative Dermatology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/525/relationships"/></api:object></api:result></api:response>